A B S T R A C T Acute serum insulin responses in 10 normal subjects after rapid intravenous injection of glucose (5 g) or isoproterenol (2 Atg) were of similar magnitude and timing (glucose: 431±349%; mean A3-5' insulin (IRI) ±SD, per cent basal and isoproterenol: 359+ 216%; mean A2-4' IRI-+-SD, per cent basal). To elucidate the relationship of glucose-induced insulin secretion to pancreatic beta adrenergic receptors and the implications of this relationship with regards to abnormal insulin secretion in diabetes mellitus, two questions were studied. (a) To determine whether glucose-induced insulin secretion is dependent upon beta adrenergic activity, the effect of beta adrenergic blockade with intravenous propranolol (0.08 mg/min) upon acute insulin responses to isoproterenol and glucose were compared in normal subjects. (b) To determine whether acute insulin responses to beta adrenergic stimulation were intact in diabetes mellitus, the effect of isoproterenol upon serum insulin levels was studied in diabetic subjects. Beta adrenergic blockade in the normal subjects obliterated acute insulin responses to isoproterenol (before: 361±270%, during: -31±15%; n = 6, P < 0.001) but did not significantly affect responses to glucose (before: 311±270%; during: 284±206%; n = 5). The mean acute insulin response after isoproterenol in the diabetic group was significantly elevated over basal levels ( 152±74%; n = 10, P < 0.001 ) but the response after glucose was not (-11+± 11%). These data suggest that insulin responses to glucose in normal subjects are mediated by specific pancreatic glucose receptors which are independent from beta adrenergic receptors and that abnormal glucose-induced insulin secretion in diabetics is due to defects within glucose receptors and not beta adrenergic receptors as has been previously hypothesized.
A B S T R A C T Acute serum insulin responses in 10 normal subjects after rapid intravenous injection of glucose (5 g) or isoproterenol (2 Atg) were of similar magnitude and timing (glucose: 431±349%; mean A3-5' insulin (IRI) ±SD, per cent basal and isoproterenol: 359+ 216%; mean A2-4' IRI-+-SD, per cent basal). To elucidate the relationship of glucose-induced insulin secretion to pancreatic beta adrenergic receptors and the implications of this relationship with regards to abnormal insulin secretion in diabetes mellitus, two questions were studied. (a) To determine whether glucose-induced insulin secretion is dependent upon beta adrenergic activity, the effect of beta adrenergic blockade with intravenous propranolol (0.08 mg/min) upon acute insulin responses to isoproterenol and glucose were compared in normal subjects. (b) To determine whether acute insulin responses to beta adrenergic stimulation were intact in diabetes mellitus, the effect of isoproterenol upon serum insulin levels was studied in diabetic subjects. Beta adrenergic blockade in the normal subjects obliterated acute insulin responses to isoproterenol (before: 361±270%, during: -31±15%; n = 6, P < 0.001) but did not significantly affect responses to glucose (before: 311±270%; during: 284±206%; n = 5). The mean acute insulin response after isoproterenol in the diabetic group was significantly elevated over basal levels ( 152±74%; n = 10, P < 0.001 ) but the response after glucose was not (-11+± 11%). These data suggest that insulin responses to glucose in normal subjects are mediated by specific pancreatic glucose receptors which are independent from beta adrenergic receptors and that abnormal glucose-induced INTRODUCTION Defects in pancreatic adenyl cyclase and cyclic AMP activity have been hypothesized to explain the failure of diabetic subjects to secrete insulin normally after glucose challenge and suspicion has specifically been cast upon the beta adrenergic receptor (1, 2), a hypothetical entity whose function is believed to depend upon adenyl cyclase and cyclic AMP. However, two questions which are critical in elucidating the relationship of glucose-induced insulin secretion to pancreatic beta adrenergic receptors and the implications of this relationship with regard to abnormal insulin secretion in diabetes mellitus have been left unanswered. (a) In normal subjects, does the insulin response to glucose depend upon beta adrenergic activity? (b) In diabetic subjects, are insulin responses to beta adrenergic stimulation intact despite abnormal responses to glucose? These questions were studied (a) by investigating the effect of beta adrenergic blockade in normal subjects upon glucose-stimulated acute insulin responeses, i.e., the response measurable in peripheral blood within 5 min after intravenous stimulation, and (b) by comparing acute insulin responses after glucose and beta adrenergic stimulation in normal and diabetic subjects.
METHODS
There were two groups of subjects: (a) normal subjects of varying degrees of obesity with no personal or family history of diabetes mellitus who responded to a request for volunteers posted on hospital bulletin boards, and (b), ambulatory diabetic subjects of varying degrees of adiposity who were noninsulin-dependent and had received no oral hypoglycemic agents for at least 5 days before testing. All studies were conducted after a 12 h fast and at bed rest between the hours of 8 a. expressed as per cent of the mean of the individual's four control values when the data was combined in the normal and diabetic groups because of previous publications (3) demonstrating a linear relationship between basal insulin level and the magnitude of response after glucose stimulation. After collection, heparinized blood samples for glucose were kept at 4°C until the end of the study, then centrifuged at 4°C, and the plasma was frozen for future analysis by the AutoAnalyzer-ferrocyanide method (4). Blood samples for insulin were allowed to clot at room temperature and then were centrifuged, and the serum was frozen for future analysis by the double antibody immunoprecipitation technique modified from Morgan and Lazarow (5).
This assay has an intraassay coefficient of variation of 10%o and an interassay coefficient of variation of 20%. All samples from one subject were analyzed in the same assay. Statistical comparisons were performed by paired t test, and correlation coefficients were derived by the Pearson Product Moment method.
RESULTS
Acute insulin responses in normal subjects after intravenous glucose and isoproterenol. All normal subjects had fasting plasma glucose levels 111 mg/100 ml (Table I) completely obliterated by propranolol (before: 361 ± 143%; during: -31±15%; P <0.001). In contrast, the glucose-stimulated response in 5/5 subjects tested was not significantly diminished when compared before (311+270%) and during (284±206%) beta blockade with the identical dose of intravenous propranolol (Table II, Fig. 3 ). Acute insulin responses in diabetic subjects after intravenous glucose and isoproterenol. All diabetic subjects had fasting plasma glucose levels > 157 mg/ml (Table I ) and varied with respect to age (46±9 yr, mean +SD), obesity (123±27%, per cent ideal body weight, mean +SD) and basal insulin level (17±11, AU/ml, mean --SD). Obesity and basal insulin level were similar in the normal and diabetic groups, but the diabetic group was significantly older (P < 0.001). All 10 subjects had no significant increase in insulin level acutely in any individual after 5 g of intravenous glucose (Table IV, Fig. 1) ; the mean response for the group was -11±11%. In striking contrast, all the dia- Isoproterenol bolus.
betic subjects had an acute insulin response after intravenous isoproterenol (Table IV, Fig. 4 ). Serum insulin levels were maximal for the group by 2 min, and base-line levels were reestablished by 15 min. The mean acute response for the group (152±74%) was significantly greater than control values (P < 0.001). Although the mean acute insulin response to isoproterenol, expressed as per cent basal, for the diabetic group was significantly less than that seen for the normal group (P < 0.02), no appreciable differences in the normal and diabetic responses could be visualized when the absolute acute insulin response for each individual was plotted as a function of his basal insulin level (Fig. 5 ).
There was no significant correlation between acute insulin response after isoproterenol and fasting plasma glucose in either the normal (r = -0.52) or diabetic (r= -0.02) groups. Plasma glucose levels were unaffected by the isoproterenol injections in both the normal and diabetic groups, and in both groups individual plasma (5 g) given in less than 3 s before and during intravenous propranolol infusion (0.08 mg/min) upon serum insulin levels in normal subjects.
glucose levels before glucose and isoproterenol injections varied less than 4±3% (mean +SD). DISCUSSION A strong argument for the existence of separate and distinct receptors within the pancreatic islet for glucose Plasma Insulin and beta adrenergic agonists can be advanced by virtue of the differential effect of beta adrenergic blockade upon the acute insulin responses to glucose and isoproterenol in the normal subjects. In the doses used, both stimuli induced acute insulin responses of similar magnitude within minutes of intravenous injection. Yet, although the responses were comparable with regard to magnitude and timing, the response to glucose stimulation was not affected by a level of beta adrenergic blockade which obliterated the response to isoproterenol stimulation. Thus, in a situation where the hypothetical pancreatic beta adrenergic receptors were unresponsive, it was possible to stimulate a normal response with glucose. The conclusion thus seems warranted that the glucosestimulated response was independent of the beta adrenergic receptor. Consequently, the need arises to postulate a separate and functionally distinct glucose receptor. Data supporting the existence of glucoreceptors has been previously published by Matschinsky, Landgraf, Ellerman, and Kotler-Brajtburg (6) and has been recently reviewed.
An argument can be marshalled against a concept of discrete and independent receptors through use of data published by Cerasi, Effendic, and Luft (1) who de- A comparison of the insulin responses after glucose and isoproterenol in the diabetic subjects provides further evidence that the glucose receptor is functionally independent of the beta adrenergic receptor. The observation that none of the diabetic subjects had an acute insulin response after glucose, but all of them had responses after isoproterenol, supports the contention that separate receptors were involved. Interestingly, the diabetic group had a significantly smaller mean acute insulin response after isoproterenol than that seen in the normal group, suggesting that the diabetic pancreas has a diminished ability to respond to beta adrenergic stimulation. It is unlikely that severity of hyperglycemia or quality of therapeutic control is the explanation for this finding since no significant correlation was found between the acute insulin response to isoproterenol and fasting plasma glucose level among individuals in either the normal or the diabetic groups. On the other hand, the 
